Nektar Therapeutics Announces Strategic Reprioritization and Cost Restructuring Plan
Go back to Nektar Therapeutics Announces Strategic Reprioritization and Cost Restructuring Plan| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 60.10 -6.74 (10.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.84 | 52 Week High | $19.98 | |||
| Open | $67.08 | 52 Week Low | $10.52 | |||
| Day High | $68.33 | P/E | N/A | |||
| Day Low | $59.44 | EPS | $-1.45 | |||
| Volume | 2,370,743 | |||||
